References
- Boey M L., Colaco C B., Gharavi A E., Elkon K B., Loizou S, Hughes G RV. Thrombosis in systemic lupus erythe-matosus: striking association with the presence of circulating lupus anticoagulant. Br Med J 1983; 287: 1021
- Carreras L O., Defreyn G, Machin S J., Vermylen J, Deman R, Spitz B. Arterial thrombosis, intrauterine death and “lupus” anticoagulant: detection of immu-noglobulin interfering with prostacyclin formation. Lancet 1981; i: 244
- Carreras L O., Vermylen J. “Lupus” anticoagulant and thrombosis. Possible role of inhibition of prostacyclin formation. Thromb Haemostas 1982; 48: 38
- Firkin B G., Booth P, Hendrix L, Howard M A. Demonstration of a platelet bypass mechanism in the clotting system using an acquired anticoagulant. Am J Hematol 1978; 5: 81
- Gabriel L, Samama M, Conard J, Horellou M H., Servelle M. Anticoagulant circulant antiprothrombi-nase, thromboses et avortements spontanés. Une nou-velle observation. Nouv Presse Med 1980; 9: 2159
- Kluft C. Studies on the fibrinolytic system in human plasma: Quantitative determination of plasminogen activators and proactivators. Thromb Haemost 1979; 41: 365
- Lubbe W F., Butler W S., Palmer S J., Liggins G C. Fetal survival after prednisone suppression of maternal lupus-anticoagulant. Lancet 1983; i: 1361
- Robertson B R., Pandolfi M, Nilsson I M. “Fibrinolytic capacity” in healthy volunteers as estimated from effect of venous occlusion of arms. Acta Chir Scand 1972; 138: 499
- Schleider M A., Nachman R L., Jaffe E A., Coleman M. A clinical study of the lupus anticoagulant. Blood 1976; 48: 499
- Soulier J P., Boffa M C. Avortements à répétition, thromboses et anticoagulant circulant anti-thrombo-plastine. Nouv Presse Med 1980; 9: 859